Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial
Year: 2010
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Institution: Florida Academic Dermatology Center
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2041193055
